Laddar populära aktier...
Soft Q1 combined with a downgrade of the FY'24 guidance Synergies unlikely to show in '24e: cutting ...
Adj. EBIT +3% y-o-y, despite a 7% sales drop y-o-y We make small estimate revisions +16% adj.
VBG Group fortsätter leverera starka resultat. Bolaget gynnas av en stark efterfrågan inom bussegmen...
Pharma Equity Group published its Q1 report for 2024 on the 16th of May, 2024.
Omsättningen kom i linje med vår prognos men resultatet pressades av höga avskrivningar.
First Venture publicerade den 15 maj 2024 bolagets delårsrapport för det första kvartalet av 2024.
Q1 EBITDAC below on costs, reiterates FY'24 guidance Expect continued positive momentum New guidance...
Redeye’s initial comments on the Q1 report from Waystream.
Idag publicerade Fable Media sin delårsrapport för kv1 2024.
Redeye leaves its initial comments on Xbrane's Q1 report, which came in softer than we had pencilled...
I dag offentliggjorde Angler Gaming sin delårsrapport för Kv1 2024.
Redeye sees a Q1 report from Genovis largely aligning with our estimates with minor deviation on the...
Somewhat surprising, the QoQ reduction in order backlog from SEK 23m in Q4’23 to SEK 15m in Q1’24 wa...
Redeye provides an update following SenzaGen’s Q1 report.
Redeye updates its estimates following Sozap’s Q1 report.